GTC Biotherapeutics (fka GTCB)

[croumagnon]

"I agree with MTB's assessment that the FOB landscape is changing in GTC's favor and Vin's view that FDA approval is a major validation of the platform"

Yes but this market stinks and other opportunities are showing up. Moreover, all what you say will be meaningless by June for GTCB shareholders because LFB will simply devour the company on the cheap at that time...

Nevertheless, GTCB is approaching my buy signal so I may end up joining you once again as a shareholder...